Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Moderna, Inc. (MRNA) had Receiveable Turnover of 5.48 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$389.00M |
|
$-1.34B |
|
$955.00M |
|
$-566.00M |
|
$1.78B |
|
$-1.39B |
|
$54.00M |
|
$-1.33B |
|
$-1.33B |
|
$-1.34B |
|
$-1.34B |
|
$-1.34B |
|
$-1.34B |
|
$-1.39B |
|
$-1.34B |
|
395.00M |
|
395.00M |
|
$-3.40 |
|
$-3.40 |
|
| Balance Sheet Financials | |
$5.77B |
|
$2.09B |
|
$5.72B |
|
$11.49B |
|
$2.40B |
|
$603.00M |
|
$1.69B |
|
$4.08B |
|
$7.41B |
|
$7.41B |
|
$7.41B |
|
397.00M |
|
| Cash Flow Statement Financials | |
$-630.00M |
|
$-76.00M |
|
$17.00M |
|
$2.60B |
|
$1.91B |
|
$-688.00M |
|
$104.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.41 |
|
-- |
|
-- |
|
0.08 |
|
0.08 |
|
-145.50% |
|
-356.81% |
|
-356.81% |
|
-- |
|
-342.93% |
|
-345.24% |
|
$-692.00M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
6.54 |
|
|
Receiveable Turnover |
5.48 |
16.43 |
|
-18.13% |
|
-18.13% |
|
-11.69% |
|
-16.76% |
|
$18.66 |
|
$-1.75 |
|
$-1.59 |
|